Parse Biosciences
Latest round
- Series C
Last raised
- Dec 2023
Total raised
- $49M
Investors
- 7
About Parse Biosciences
Founded in 2018 and based in Seattle, US, Parse Biosciences, Inc. specializing in innovative single-cell sequencing technologies, enabling researchers to analyze millions of cells efficiently. Their solutions empower advancements in multiple fields, including immunology and cancer research. Parse Biosciences focuses on developing scalable single-cell sequencing technologies.V. agreed to fully acquire Parse Biosciences, Inc. The company will receive an additional USD 55 million in further contingent payments based on achieving certain milestones.Parse Biosciences offers scalable single-cell sequencing technologies, primarily through its flagship Evercode™ series. This includes the Evercode WT (Whole Transcriptome) kits, which allow analysis of up to 5 million cells in one experiment. The company's solutions streamline library preparation, providing immediate analytical results via the Trailmaker software.The company generates revenue through the sale of its Evercode™ products and related solutions, primarily engaging with research institutions and corporate clients. Products are often part of larger research projects and may include subscription models for software and data analysis. The pricing structure caters to specific user needs, featuring both standalone products and bundled services. Key offerings such as the Evercode WT Mega and Evercode TCR/BCR play a significant role in their revenue model, meeting the demand for high-throughput sequencing solutions in life sciences.
Who invested in Parse Biosciences
7 investors across 3 rounds
See all investors in Parse Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Parse Biosciences
Who invested in Parse Biosciences?
Parse Biosciences has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Parse Biosciences raised?
Parse Biosciences has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Parse Biosciences last raise money?
Parse Biosciences's most recent round on record is a Series C, in Dec 2023.
What does Parse Biosciences do?
Founded in 2018 and based in Seattle, US, Parse Biosciences, Inc.
Where is Parse Biosciences headquartered?
Parse Biosciences is headquartered in Seattle, US.
Which VCs invest in companies like Parse Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Parse Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Parse Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.